Compugen Ltd reports results for the quarter ended September 30 - Earnings Summary

• Compugen Ltd CGEN.OQ reported quarterly adjusted earnings of 1 cent​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -11 cents. The mean expectation of three analysts for the quarter was for earnings of 11 cents per share. Wall Street expected results to range from -10 cents to 21 cents per share.

• Revenue was $17.13 million​; analysts expected $17.86 million.

• Compugen Ltd's reported EPS for the quarter was 1 cent​.

• The company reported quarterly net income of $1.28 million.

• Compugen Ltd shares had fallen by 3.9% this quarter and lost 12.1% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 49.4% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the biotechnology & medical research peer group is also "strong buy"

Wall Street's median 12-month price target for Compugen Ltd is 4.00

This summary was machine generated from LSEG data November 12 at 03:34 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)